keke
Lv51
950 积分
2022-11-17 加入
-
Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study
2小时前
待确认
-
Efruxifermin combined with a GLP-1 receptor agonist reduces liver fat in NASH
16天前
已完结
-
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
16天前
已完结
-
Current status and future perspectives of FGF21 analogues in clinical trials
25天前
已完结
-
Proprotein convertase subtilisin/kexin type 9 targets megalin in the kidney proximal tubule and aggravates proteinuria in nephrotic syndrome
2个月前
已完结
-
Inhibition of an immunometabolic axis of mTORC1 activation extends mammalian healthspan
2个月前
已完结
-
Abstract 2365: Disrupting IL-11/IL-11R signaling by an efficacious anti-IL-11 antibody 9MW3811 enhances T cell tumor infiltration and synergizes with anti-PD-1 therapies in vivo
2个月前
已关闭
-
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
2个月前
已完结
-
Preparation, characterization, and pharmacological study of a novel long-acting FGF21 with a potential therapeutic effect in obesity
6个月前
已完结
-
RELATIONSHIPS BETWEEN THE STRUCTURES AND ACTIVITIES OF SOME MICROBIAL SERINE PROTEASES. I. PURIFICATION, ENZYMIC PROPERTIES AND PRIMARY STRUCUTRES OF STREPTOMYCES GRISEUS PROTEASES A, B AND TRYPSIN
1年前
已关闭